secwatch.observer — SEC 8-K summary
======================================

Issuer:     Actinium Pharmaceuticals, Inc. (ATNM)
CIK:        0001388320
Form:       8-K
Filed at:   2022-12-30T23:59:59+00:00
Accession:  0001213900-22-084094
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Actinium shareholders approve 3.5M share increase for 2019 Plan; Shetty re-elected
--------------------------------------------------------------------------------

- Shareholders approved an amendment to the 2019 Stock Plan increasing authorized shares by 3.5M to a total of 9,333,333 shares.
- The proposal passed with 8,780,109 votes for, 8,533,767 against, and 103,453 abstentions, a narrow margin.
- Ajit S. Shetty was elected as Class III director for a three-year term with 9,814,712 votes for and 2,964,185 against.
- Shareholders ratified Marcum LLP as independent auditor for FY2022 with 16,368,122 votes for.
- Non-binding advisory vote on executive compensation passed with 9,832,125 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388320/000121390022084094/0001213900-22-084094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388320/000121390022084094/ea171085-8k_actinium.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-084094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer